Evidence map›Paper›PMID 34615370›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2021

AGGF1 Shows the α5β1 Integrin to Be Another

Feilim Mac Gabhann, Brian H Annex

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Feilim Mac GabhannDepartment of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (F.M.G.).
Brian H AnnexVascular Biology Center and Department of Medicine, Medical College of Georgia at Augusta University (B.H.A.).ORCID 0000-0001-6538-8243

Funding

Systems Biology of Angiogenesis in Peripheral Arterial DiseaseR01HL101200 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POPEL, ALEKSANDER S. · 2010 to 2022
$10.7M
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PADR01HL150003 · NHLBI · AUGUSTA UNIVERSITY · PI ANNEX, BRIAN H, MCCLUNG, JOSEPH MATTHEW · 2020 to 2023
$3.0M
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R PathwayR01HL148590 · NHLBI · AUGUSTA UNIVERSITY · PI ANNEX, BRIAN H · 2019 to 2022
$2.9M
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery DiseaseR01HL141325 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H · 2019 to 2022
$2.7M
New Roles for VEGFR1 in AngiogenesisR01GM129074 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI MAC GABHANN, FEILIM C · 2018 to 2021
$2.6M
NHLBI NIH HHS R01 HL101200NHLBI NIH HHS R01 HL141325NHLBI NIH HHS R01 HL148590NHLBI NIH HHS R01 HL150003NIGMS NIH HHS R01 GM129074
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IntegrinsProto-Oncogene Proteins c-aktAngiogenic ProteinsHumansNeovascularization, PathologicPhosphatidylinositol 3-KinasesProto-Oncogene MasAGGF1 protein, humanAngiogenic ProteinsIntegrinsMAS1 protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene MasProto-Oncogene Proteins c-aktangiogenic proteinsEditorialsintegrinsmorphogenesisproto-oncogene proteins c-aktsystems biology

Identifiers

PMID34615370
PMCPMC8551031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.